The Wilmington, Delaware-based company said it had profit of $1.09 per share. Earnings, adjusted for non-recurring costs, came to $1.11 per share. The results exceeded Wall Street expectations. The ...

Drugmaker Incyte Corp reported fourth-quarter revenue above Wall Street estimates on Monday, boosted by strong demand for its key blood-cancer drug Jakafi and skin-disorder treatment Opzelura.

Today, the Wall Street Journal and the New York Times reported that Meta, a company worth $1.7 trillion, plans to move their incorporation out of Delaware in response to Chancery Court overreach. The ...